Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 14, 2020 10:01 AM 11 min read

Benzinga's Top Upgrades, Downgrades For October 14, 2020

by Benzinga Insights Benzinga Staff Writer
Follow

Upgrades

  • For AnaptysBio Inc (NASDAQ:ANAB), Guggenheim upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, AnaptysBio showed an EPS of $0.79, compared to $0.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of 39.48 and a 52-week-low of 10.0. AnaptysBio closed at $17.76 at the end of the last trading period.
  • According to Loop Capital, the prior rating for American Eagle Outfitters Inc (NYSE:AEO) was changed from Sell to Hold. In the second quarter, American Eagle Outfitters showed an EPS of $0.03, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of 16.825 and a 52-week-low of 6.535. American Eagle Outfitters closed at $14.80 at the end of the last trading period.
  • According to UBS, the prior rating for Workday Inc (NASDAQ:WDAY) was changed from Sell to Neutral. In the second quarter, Workday showed an EPS of $0.84, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of 248.75 and a 52-week-low of 107.75. At the end of the last trading period, Workday closed at $232.90.
  • For AutoZone Inc (NYSE:AZO), Raymond James upgraded the previous rating of Outperform to the current rating Strong Buy. AutoZone earned $30.93 in the fourth quarter, compared to $20.95 in the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of 1274.4075 and a 52-week-low of 684.91. Moreover, at the end of the last trading period, the closing price was at $1165.71.
  • JP Morgan upgraded the previous rating for NIO Inc (NYSE:NIO) from Neutral to Overweight. NIO earned $0.15 in the second quarter, compared to $0.45 in the year-ago quarter. The current stock performance of NIO shows a 52-week-high of 22.59 and a 52-week-low of 1.36. Moreover, at the end of the last trading period, the closing price was at $21.61.
  • According to Jefferies, the prior rating for Beacon Roofing Supply Inc (NASDAQ:BECN) was changed from Hold to Buy. For the third quarter, Beacon Roofing Supply had an EPS of $1.01, compared to year-ago quarter EPS of $0.32. The stock has a 52-week-high of 37.06 and a 52-week-low of 11.665. At the end of the last trading period, Beacon Roofing Supply closed at $35.43.
  • For Theravance Biopharma Inc (NASDAQ:TBPH), Morgan Stanley upgraded the previous rating of Equal-Weight to the current rating Overweight. Theravance Biopharma earned $1.00 in the second quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of 31.54 and a 52-week-low of 14.48. Theravance Biopharma closed at $17.28 at the end of the last trading period.

 

 

Downgrades

 

Initiations

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInitiationstop upgrades
AEO Logo
AEOAmerican Eagle Outfitters Inc
$24.650.33%
Overview
ALB Logo
ALBAlbemarle Corp
$178.990.18%
ANAB Logo
ANABAnaptysBio Inc
$55.05-%
AZO Logo
AZOAutoZone Inc
$3755.58-%
CALX Logo
CALXCalix Inc
$51.77-%
CMPS Logo
CMPSCompass Pathways PLC
$6.960.87%
CRM Logo
CRMSalesforce Inc
$194.46-0.17%
DOCU Logo
DOCUDocusign Inc
$45.05-0.04%
MSFT Logo
MSFTMicrosoft Corp
$394.170.36%
NIO Logo
NIONIO Inc
$4.880.21%
NIU Logo
NIUNiu Technologies
$3.650.83%
NOW Logo
NOWServiceNow Inc
$108.060.05%
NTLA Logo
NTLAIntellia Therapeutics Inc
$13.77-0.08%
NYT Logo
NYTNew York Times Co
$79.79-%
ORCL Logo
ORCLOracle Corp
$144.69-0.49%
PNR Logo
PNRPentair PLC
$99.11-0.08%
STZ Logo
STZConstellation Brands Inc
$157.86-%
TBPH Logo
TBPHTheravance Biopharma Inc
$18.15-0.55%
U Logo
UUnity Software Inc
$18.14-0.49%
VEEV Logo
VEEVVeeva Systems Inc
$181.98-0.02%
WDAY Logo
WDAYWorkday Inc
$133.72-0.03%
WST Logo
WSTWest Pharmaceutical Services Inc
$254.34-%
  • B of A Securities downgraded the previous rating for Paramount Group Inc (NYSE:PGRE) from Neutral to Underperform. In the second quarter, Paramount Group showed an EPS of $0.23, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of 15.0 and a 52-week-low of 6.42. Paramount Group closed at $7.00 at the end of the last trading period.
  • According to UBS, the prior rating for Splunk Inc (NASDAQ:SPLK) was changed from Buy to Sell. For the second quarter, Splunk had an EPS of $0.33, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of 225.8944 and a 52-week-low of 93.92. Splunk closed at $215.83 at the end of the last trading period.
  • For Constellation Brands Inc (NYSE:STZ), Atlantic Equities downgraded the previous rating of Overweight to the current rating Neutral. For the second quarter, Constellation Brands had an EPS of $2.76, compared to year-ago quarter EPS of $2.72. At the moment, the stock has a 52-week-high of 208.55 and a 52-week-low of 104.28. Constellation Brands closed at $187.57 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Invitae Corp (NYSE:NVTA) was changed from Overweight to Neutral. For the second quarter, Invitae had an EPS of $0.77, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of 55.38 and a 52-week-low of 7.415. At the end of the last trading period, Invitae closed at $52.59.
  • For Livongo Health Inc (NASDAQ:LVGO), JP Morgan downgraded the previous rating of Overweight to the current rating Neutral. In the second quarter, Livongo Health showed an EPS of $0.11, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of 151.049 and a 52-week-low of 17.25. At the end of the last trading period, Livongo Health closed at $148.08.
  • For Albemarle Corp (NYSE:ALB), RBC Capital downgraded the previous rating of Sector Perform to the current rating Underperform. For the second quarter, Albemarle had an EPS of $0.86, compared to year-ago quarter EPS of $1.55. At the moment, the stock has a 52-week-high of 101.0 and a 52-week-low of 48.8901. Albemarle closed at $95.10 at the end of the last trading period.
  • KeyBanc downgraded the previous rating for Pentair PLC (NYSE:PNR) from Overweight to Sector Weight. For the second quarter, Pentair had an EPS of $0.59, compared to year-ago quarter EPS of $0.69. At the moment, the stock has a 52-week-high of 50.52 and a 52-week-low of 22.01. Pentair closed at $49.28 at the end of the last trading period.
  • With a current rating of Equal-Weight, Stephens & Co. initiated coverage on West Pharmaceutical Services Inc (NYSE:WST). The price target seems to have been set at $300.00 for West Pharmaceutical Servs. For the second quarter, West Pharmaceutical Servs had an EPS of $1.25, compared to year-ago quarter EPS of $0.89. The current stock performance of West Pharmaceutical Servs shows a 52-week-high of 303.14 and a 52-week-low of 124.53. Moreover, at the end of the last trading period, the closing price was at $299.45.
  • With a current rating of Buy, Citigroup initiated coverage on PNM Resources Inc (NYSE:PNM). The price target seems to have been set at $51.00 for PNM Resources. In the second quarter, PNM Resources showed an EPS of $0.55, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of 56.14 and a 52-week-low of 27.08. PNM Resources closed at $45.50 at the end of the last trading period.
  • With a current rating of Buy, Deutsche Bank initiated coverage on 1Life Healthcare Inc (NASDAQ:ONEM). The price target seems to have been set at $37.00 for 1Life Healthcare. 1Life Healthcare earned $0.24 in the second quarter. The current stock performance of 1Life Healthcare shows a 52-week-high of 44.87 and a 52-week-low of 15.0. Moreover, at the end of the last trading period, the closing price was at $29.70.
  • UBS initiated coverage on VMware Inc (NYSE:VMW) with a Neutral rating. The price target for VMware is set to $155.00. VMware earned $1.81 in the second quarter, compared to $1.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of 173.37 and a 52-week-low of 86.0. VMware closed at $155.04 at the end of the last trading period.
  • UBS initiated coverage on Veeva Systems Inc (NYSE:VEEV) with a Sell rating. The price target for Veeva Systems is set to $225.00. For the second quarter, Veeva Systems had an EPS of $0.72, compared to year-ago quarter EPS of $0.55. At the moment, the stock has a 52-week-high of 312.0 and a 52-week-low of 118.11. Veeva Systems closed at $308.84 at the end of the last trading period.
  • UBS initiated coverage on Oracle Corp (NYSE:ORCL) with a Neutral rating. The price target for Oracle is set to $62.00. For the first quarter, Oracle had an EPS of $0.93, compared to year-ago quarter EPS of $0.81. At the moment, the stock has a 52-week-high of 62.5999 and a 52-week-low of 39.71. Oracle closed at $60.97 at the end of the last trading period.
  • Morgan Stanley initiated coverage on New York Times Co (NYSE:NYT) with an Overweight rating. The price target for New York Times is set to $55.00. In the second quarter, New York Times showed an EPS of $0.18, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of 47.95 and a 52-week-low of 26.13. New York Times closed at $43.41 at the end of the last trading period.
  • For Intellia Therapeutics Inc (NASDAQ:NTLA), Wells Fargo initiated coverage, by setting the current rating at Overweight. Intellia Therapeutics earned $0.61 in the second quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of 26.77 and a 52-week-low of 9.18. Intellia Therapeutics closed at $24.61 at the end of the last trading period.
  • UBS initiated coverage on ServiceNow Inc (NYSE:NOW) with a Buy rating. The price target for ServiceNow is set to $600.00. In the second quarter, ServiceNow showed an EPS of $1.23, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of 522.77 and a 52-week-low of 213.99. At the end of the last trading period, ServiceNow closed at $518.22.
  • HC Wainwright & Co. initiated coverage on Compass Pathways PLC (NASDAQ:CMPS) with a Buy rating. The price target for Compass Pathways is set to $65.00. The current stock performance of Compass Pathways shows a 52-week-high of 47.29 and a 52-week-low of 22.51. Moreover, at the end of the last trading period, the closing price was at $38.82.
  • With a current rating of Outperform, CICC initiated coverage on Niu Technologies (NASDAQ:NIU). The price target seems to have been set at $31.00 for Niu Technologies. In the second quarter, Niu Technologies showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of 28.4899 and a 52-week-low of 6.08. At the end of the last trading period, Niu Technologies closed at $27.37.
  • UBS initiated coverage on Microsoft Corp (NASDAQ:MSFT) with a Buy rating. The price target for Microsoft is set to $243.00. For the fourth quarter, Microsoft had an EPS of $1.46, compared to year-ago quarter EPS of $1.37. At the moment, the stock has a 52-week-high of 232.86 and a 52-week-low of 132.52. Microsoft closed at $222.86 at the end of the last trading period.
  • UBS initiated coverage on DocuSign Inc (NASDAQ:DOCU) with a Buy rating. The price target for DocuSign is set to $290.00. For the second quarter, DocuSign had an EPS of $0.17, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of 290.23 and a 52-week-low of 61.68. At the end of the last trading period, DocuSign closed at $238.21.
  • UBS initiated coverage on Citrix Systems Inc (NASDAQ:CTXS) with a Neutral rating. The price target for Citrix Systems is set to $146.00. For the second quarter, Citrix Systems had an EPS of $1.53, compared to year-ago quarter EPS of $1.21. At the moment, the stock has a 52-week-high of 173.56 and a 52-week-low of 97.45. Citrix Systems closed at $144.03 at the end of the last trading period.
  • UBS initiated coverage on Salesforce.com Inc (NYSE:CRM) with a Buy rating. The price target for Salesforce.com is set to $325.00. For the second quarter, Salesforce.com had an EPS of $1.44, compared to year-ago quarter EPS of $0.66. At the moment, the stock has a 52-week-high of 284.5 and a 52-week-low of 115.29. Salesforce.com closed at $266.76 at the end of the last trading period.
  • With a current rating of Buy, HC Wainwright & Co. initiated coverage on Humanigen Inc (NASDAQ:HGEN). The price target seems to have been set at $31.00 for Humanigen. Humanigen earned $0.16 in the second quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of 33.95 and a 52-week-low of 3.4. Humanigen closed at $12.03 at the end of the last trading period.
  • With a current rating of Buy, Needham initiated coverage on Calix Inc (NYSE:CALX). The price target seems to have been set at $25.00 for Calix. Calix earned $0.14 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of 22.69 and a 52-week-low of 5.61. At the end of the last trading period, Calix closed at $19.50.
  • Wedbush initiated coverage on Unity Software Inc (NYSE:U) with an Outperform rating. The price target for Unity Software is set to $125.00. The current stock performance of Unity Software shows a 52-week-high of 102.63 and a 52-week-low of 65.11. Moreover, at the end of the last trading period, the closing price was at $92.19.
AEO Logo
AEOAmerican Eagle Outfitters Inc
$24.650.33%
Overview
ALB Logo
ALBAlbemarle Corp
$178.990.18%
ANAB Logo
ANABAnaptysBio Inc
$55.05-%
AZO Logo
AZOAutoZone Inc
$3755.58-%
CALX Logo
CALXCalix Inc
$51.77-%
CMPS Logo
CMPSCompass Pathways PLC
$6.960.87%
CRM Logo
CRMSalesforce Inc
$194.46-0.17%
DOCU Logo
DOCUDocusign Inc
$45.05-0.04%
MSFT Logo
MSFTMicrosoft Corp
$394.170.36%
NIO Logo
NIONIO Inc
$4.880.21%
NIU Logo
NIUNiu Technologies
$3.650.83%
NOW Logo
NOWServiceNow Inc
$108.060.05%
NTLA Logo
NTLAIntellia Therapeutics Inc
$13.77-0.08%
NYT Logo
NYTNew York Times Co
$79.79-%
ORCL Logo
ORCLOracle Corp
$144.69-0.49%
PNR Logo
PNRPentair PLC
$99.11-0.08%
STZ Logo
STZConstellation Brands Inc
$157.86-%
TBPH Logo
TBPHTheravance Biopharma Inc
$18.15-0.55%
U Logo
UUnity Software Inc
$18.14-0.49%
VEEV Logo
VEEVVeeva Systems Inc
$181.98-0.02%
WDAY Logo
WDAYWorkday Inc
$133.72-0.03%
WST Logo
WSTWest Pharmaceutical Services Inc
$254.34-%
Comments
Loading...